Loading...

Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study

OBJECTIVES: Ankylosing spondylitis (AS) is associated with an increased spinal fracture risk due to the loss of elasticity in spinal motion segments. With the introduction of biological disease-modifying antirheumatic drug (bDMARD) treatment for AS, the individual course of the disease has been amel...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Open
Main Authors: Robinson, Yohan, Olerud, Claes, Willander, Johan
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5770921/
https://ncbi.nlm.nih.gov/pubmed/29288176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-016548
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!